COVID-19 Treatment Pharmacy And Clinic Locations

Over 30 columns detail pharmacies, clinics, and Test to Treat sites with COVID-19 therapeutics like Paxlovid and Lagevrio. The dataset from datahub.hhs.gov lists locations self-reporting inventory within the last two months, though updates ceased in December 2024. It includes provider details, medication availability flags, and geographic coordinates.

Use Cases

• Map treatment access by analyzing `Latitude`, `Longitude`, and `State` columns against `Has Paxlovid` or `Has Lagevrio` flags.
• Identify Test to Treat sites for patient referral programs using the `Is T2T Site` and `Public Phone Number` fields.
• Assess government versus commercial supply distribution by comparing `Has USG Paxlovid` and `Has Commercial Paxlovid` columns.
• Analyze reporting timeliness and potential data staleness using the `Last Report Date` field.
• Filter for telehealth or home delivery options using `Telehealth Website` and `Home Delivery` columns for remote care studies.

Strengths

• Includes geospatial data via `Latitude`, `Longitude`, and `Geopoint` columns for mapping.
• Tracks multiple specific therapeutics (Paxlovid, Lagevrio, Veklury) across over 30 detailed attributes.
• Distinguishes between US government-supplied and commercially purchased inventory through dedicated flag columns.

Limitations

• Dataset is no longer updated as of December 2024, making all information potentially stale.
• Inventory data relies on self-attestation from providers without independent verification.
• Coverage is incomplete as the description notes many treatment locations may not be included.

Provenance

Source

datahub.hhs.gov

Collection Method

Locations self-reported inventory or participation in assistance programs.

Time Range

null

Freshness

null

Geography

United States (inferred from state columns and HHS source)